(See the article by Frickel et al., on pages 1625-33.)
The concept of immunodominance during infection involves the generation of a focused immune response to a few of the many possible pathogen-derived antigenic determinants. The development of technical approaches to identify these antigens and predictive algorithms for major histocompatibility complex (MHC)-binding peptides have proven key in starting to dissect these events. When combined with the availability of MHC I and II tetramers to identify pathogen specific CD8 ϩ and CD4 ϩ T cells, these methods have provided many insights into the basic biology of an immune response. These approaches have revealed that a limited number of immunodominant epitopes account for the majority of the pathogen specific CD8 ϩ T cell responses for pathogens like Listeria, influenza, and HIV. Although this might be expected for organisms with small genomes, for more complex viruses and bacteria it is unexpected. Consequently, the question of why certain antigens become immunodominant has been a topic of much research over the last 30 years. Parasitic organisms are relatively large pathogens with complex life cycles that may involve migration through diverse tissues during development, and these organisms express literally thousands of proteins. Thus, it seems intuitive that during infections with such organisms, the immune system would recognize a multitude of pathogen-derived antigenic determinants. This is exemplified by studies with the opportunistic pathogen Toxoplasma gondii, an important cause of congenital disease and toxoplasmic encephalitis in immunocompromised individuals. CD8 ϩ T cells play a critical role in the control of this organism, and there have been numerous studies-using functional assays to measure cytokine production or cytolytic activity-that have focused on trying to identify which epitopes are recognized by CD8 ϩ T cells and which might be important vaccine candidates [1] . However, multiple attempts by several groups to identify class I-restricted epitopes to this opportunistic organism have been unable to do so. One of the reasons that contributed to this limited success was the lack of information and molecular tools to identify which parasite antigens might be involved in these processes. Recently, in an attempt to follow an endogenous immune response to T. gondii, several groups have utilized transgenic parasites that express various model antigens in conjunction with specific MHC tetramers and transgenic mice that express the T cell receptor for these antigens [2] [3] [4] [5] [6] . While information obtained using these approaches has proven useful in understanding some of the events that regulate the evolution of the T cell repertoire as well as antigen presentation, it tells us little about the natural hierarchy by which pathogen antigens are recognized and whether this changes with time.
In this issue of the Journal, Frickel et al. [7] used UV-sensitive caged tetramers to discover endogenous CD8 ϩ T cell epitopes to T. gondii. This technique, first described by Toebes et al., was used to identify T cell epitopes within the H5N1 influenza genome [8] and has since been used in human and mouse systems to characterize relevant class I-restricted epitopes from melanoma and Chlamydia, respectively [9, 10] . The ability to generate MHC molecules requires folding around an appropriate peptide to allow stabilization of the MHC molecule. Using conditional peptides that degrade after UV exposure allows complete MHC folding and safe removal of the conditional peptide without damaging the MHC molecule. If UV exposure occurs in the presence of a test peptide that is capable of binding in the empty MHC groove, this will generate a new class I-peptide complex. This peptide exchange process al-lows the generation of large numbers of MHC ligands, presenting a wide range of epitopes that can be used for highthroughput screening of antigen-specific T cells, a process that in the past would have been extremely lengthy, involving the folding of individual MHC peptidespecific tetramers.
In the present work, Frickel et al. [7] have used a BALB/c H-2L d MHC tetramer loaded with parasite-derived peptides to identify antigen-specific CD8 ϩ T cells induced during toxoplasmosis. Likely candidates were established by using the Toxoplasma genome database (http:// www.toxodb.org/toxo/) and narrowed to known tachyzoite-secreted proteins by removing those that were expressed only in the latent bradyzoite stage or with a predicted GPI anchor. This led to a list of 73 proteins and, by use of class I prediction algorithms, approximately 250 different individual peptides. These were used in the peptide exchange process to generate tetramers, which in turn allowed the identification of 2 dominant epitopes present in the GRA4 and ROP7 proteins as targets for CD8 ϩ T cells. This information was then used to describe the kinetics of these parasite-specific T cell populations, and it revealed that the T cell response to GRA4 dominates at the acute stage of infection, whereas the population of T cells specific for ROP7 expands when the infection is chronic and are found most prominently in the brain. These latter findings implicate stage conversion from the fast-replicating tachyzoite to the chronic cyst-forming bradyzoite as having a fundamental impact on the repertoire of antigens recognized by CD8 ϩ T cells during toxoplasmosis.
In parallel, recently published studies, Shastri et al. [11] used an unbiased expression cloning approach to identify immunodominant epitopes from T. gondii recognized by BALB/c mice. By using this more orthodox approach (which was still a labor of love), they generated Toxoplasma-reactive T cell hybridomas that expressed an activation-induced reporter. These cells were then used to screen a T. gondii expression library in fibroblasts that express H-2L d , and this, in turn, resulted in the identification of GRA6 as being responsible for a significant proportion of parasite-specific CD8 ϩ T cells. As part of these studies, they have also delineated additional elements required for processing of T. gondii-derived antigens and highlighted the need for peptide trimming and processing in the endoplasmic reticulum for successful presentation.
When taken together, these 2 studies raise several new issues. Perhaps the most obvious questions is what is it about these proteins that make them preferentially recognized? Interestingly, the dense granule proteins GRA4 and GRA6 are both secreted by T. gondii into the parasitophorous vacuole (PV) and have been shown to form part of a multimeric complex that is stably associated with an intravacuolar network [12] . ROP7 is also secreted into the PV and, like the GRA proteins, is part of a large family of proteins that play roles in cell invasion and the virulence of this parasite [13] , and their identification as dominant epitopes of the effector T cell response corroborates previous work that identified GRA4 as a protective antigen [14] . The fact that all 3 are secreted is consistent with previous studies using transgenic Toxoplasma that express model antigens, which concluded that secreted antigens were preferentially recognized [2] . Nevertheless, the genome predicts the presence of many secreted antigens and, thus, the relative abundance and timing of expression may be important aspects of how specific epitopes might come to dominate the T cell repertoire.
The other, perhaps more contentious, issue is that although GRA6 clearly represents an immunodominant antigen in BALB/c mice, Blanchard et al. [11] propose that it is the only parasite epitope recognized in the H-2L d haplotype. However, the studies of Frickel et al. [7] indicate that there are at least 2 other major antigens that, combined, may account for approximately 5%-10% of the total parasite-specific CD8 ϩ T cells. Given the numerous restrictions that were used in choosing candidate peptides, Frickel et al. [7] acknowledge that it is likely that this represents an underestimate of the numbers of epitopes that can be identified by using this approach. Moreover, based on an analysis of the proportion of CD8 ϩ T cells in the brain that are specific for these 3 epitopes (30%-40%), it seems probable that there will be additional antigenic determinants recognized by CD8 ϩ T cells. Whether the population structure of the CD8 ϩ T cell responses to T. gondii in these mice is indeed dominated by a very limited number of epitopes (such as GRA6) but is also composed of multiple other epitopes needs to be better defined, and whether this type of pattern will be apparent in other MHC haplotypes infected with T. gondii has yet to be tested. Nevertheless, what is clear is that armed with the information contained in these publications, it will be possible to address these questions directly.
For the immunologists who study T. gondii, these reports have tremendously advanced our insight into the development of the parasite-specific CD8 ϩ T cell response in several ways. First, the identification of 3 well-characterized endogenous epitopes has provided important new tools that will allow better insight into the evolution of the cytolytic effectors required to control T. gondii. Second, these epitopes are targets of the CD8 ϩ T cell response, and it is this effector population that should be an important focus of vaccine development, as implied by the protective response generated by GRA6-pulsed dendritic cells [11] . Consequently, these results confirm the need to focus on secreted proteins from T. gondii as likely vaccine candidates and highlight the fact that those proteins involved in some of the earliest host-pathogen interactions may represent the antigens that most profoundly influence the developing T cell repertoire, simply because they are the first presented. Lastly, for the wider field of infectious diseases, both of these recent studies illustrate the power of combining disciplines: genomics, proteomics, and functional immunology. For infections in which the bug proves difficult to maintain in vitro, and/or impossible to genetically manipulate, the use of caged tetramers will prove invaluable for identifying relevant peptides in a high-throughput fashion.
